Surmodics | SRDX - Attività Correnti





Attività Correnti Cambiamento Data
Abbott USD 25.51B 488M 2026-03
Align Technology USD 2.66B 38.87M 2026-03
Anika Therapeutics USD 93.56M 9.8M 2026-03
Arrowhead Research USD 1.17B 223.75M 2025-12
Artivion USD 358.08M 20.58M 2025-12
Baxter International USD 6.85B 25M 2026-03
Boston Scientific USD 8.68B 110M 2026-03
EDAP TMS EUR 44.35M 7.13M 2025-09
Edwards Lifesciences USD 6.74B 380M 2025-12
Haemonetics USD 943.67M 43.99M 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
J&J USD 59.17B 3.55B 2026-03
Merit Medical Systems USD 1.1B 61.62M 2026-03
Mesa Laboratories USD 105.63M 8.2M 2025-12
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Option Care Health USD 1.2B 69.86M 2026-03
Stryker USD 13.34B 1.42B 2026-03
Surmodics USD 75.99M 5.31M 2025-06
Trinity Biotech USD 35.52M 2.52M 2025-09